ACETAMINOPHEN, DEXTROMETHORPHAN HBr, GUAIFENESIN, PSEUDOEPHEDRINE HCl · PSEUDOEPHEDRINE HYDROCHLORIDE 60 mg/1; ACETAMINOPHEN 325 mg/1; DEXTROMETHORPHAN HYDROBROMIDE 20 mg/1; GUAIFENESIN 200 mg/1 · Tablet · Oral · Poly Pharmaceuticals, Inc.
NDC 50991-0535-01 · 100 TABLET in 1 BOTTLE · OTC MONOGRAPH DRUG · View full market →
Only one company currently supplies this market — there is no backup if it stumbles. The price has held steady around $0.9041 per unit over the past year. Put together: worth watching — several of the pressures that precede supply trouble are present at once.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Medicare Part D does not cover over-the-counter drugs — by law it pays only for products requiring a prescription.
How Part D pricing works →Estimates: latest NADAC unit price × quantity. Pharmacy acquisition cost only — excludes dispensing fees, markup, and insurance terms.
The score is counting real pressure here. One of these alone is routine; it’s the combination that makes this market worth watching.
The score counts pressure that is already visible — fewer makers, shortages, recalls, falling prices. 0 means none of it; 100 means all of it at once. Recomputed daily · as of Sep 3, 2026
sole-source market
For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.
Backtested statistical model over the whole market, not this package alone. Model details →
There's no legal definition — it meets 1 of 6 public criteria. Why that matters →
No FDA shortage reports for this drug or its presentations.
No enforcement reports list this package NDC.
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Poly Pharmaceuticals, Inc. | PSEUDOEPHEDRINE HYDROCHLORIDE 60 mg/1; ACETAMINOPHEN 325 mg/1; DEXTROMETHORPHAN HYDROBROMIDE 20 mg/1; GUAIFENESIN 200 mg/1 | Aug 26, 2026 | Sep 2, 2026 |
| Poly Pharmaceuticals, Inc. | PSEUDOEPHEDRINE HYDROCHLORIDE 325 mg/1; ACETAMINOPHEN 20 mg/1; DEXTROMETHORPHAN HYDROBROMIDE 200 mg/1; GUAIFENESIN 60 mg/1 | Jul 22, 2026 | Aug 19, 2026 |
| Poly Pharmaceuticals, Inc. | ACETAMINOPHEN 325 mg/1; DEXTROMETHORPHAN HYDROBROMIDE 20 mg/1; GUAIFENESIN 200 mg/1; PSEUDOEPHEDRINE HYDROCHLORIDE 60 mg/1 | Jul 15, 2026 | Jul 15, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
DrugDashboards, "Duraflu — NDC 50991-0535-01," retrieved September 3, 2026, https://drugdashboards.com/drug/50991053501.
Free to cite with attribution — see how the data is put together.